A Study on the Safety and Efficacy of LAE001 in the Treatment of Metastatic Prostate Cancer

Clinical trial NCT03843918 · TERMINATED

Trial details

NCT number: NCT03843918
Sponsor: Laekna Limited
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic

Start date: 2019-04-05
Primary completion: 2023-10-09
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.